Physiologically-based model for ketoconazole disposition and prediction of its drug-drug interactions

被引：0
|
作者：
Fraczkiewicz, Grazyna [1 ]
Parrott, Neil [2 ]
Lukacova, Viera [1 ]
Bolger, Michael B. [1 ]
Crison, John R. [1 ]
Woltosz, Walter S. [1 ]
Lave, Thierry [3 ]
机构：
[1] Simulat Plus Inc, Nonclin Dev Drug Safety, Lancaster, CA 93534 USA
[2] F Hoffmann La Roche Ltd, Dept Nonclin Drug Safety 69 154, CH-4070 Basel, Switzerland
[3] Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
168
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [1] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [2] Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions
    Sahasrabudhe, Siddhee A.
    Cheng, Shen
    Al-Kofahi, Mahmoud
    Jarnes, Jeanine R.
    Weinreb, Neal J.
    Kartha, Reena, V
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1254 - 1263
  • [3] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [4] A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug-Drug Interaction Perpetrators
    Marok, Fatima Zahra
    Wojtyniak, Jan-Georg
    Fuhr, Laura Maria
    Selzer, Dominik
    Schwab, Matthias
    Weiss, Johanna
    Haefeli, Walter Emil
    Lehr, Thorsten
    [J]. PHARMACEUTICS, 2023, 15 (02)
  • [5] A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions
    Conner, Todd M.
    Reed, Ronald C.
    Zhang, Tao
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (03) : 389 - 408
  • [6] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ATORVASTATIN AND RELATED SPECIES AND PREDICTION OF DRUG-DRUG INTERACTIONS IN HUMANS.
    Morse, B. L.
    Alberts, J. J.
    Kolur, A.
    Posada, M. M.
    Tham, L.
    Loghin, C.
    Hall, S. D.
    Dickinson, G. L.
    Hillgren, K. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S63 - S64
  • [7] Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
    Xue, Caifu
    Zhang, Xunjie
    Cai, Weimin
    [J]. PHARMACEUTICS, 2018, 10 (01):
  • [8] Physiologically-Based Pharmacokinetic Model-Informed Drug Development for Fenebrutinib: Understanding Complex Drug-Drug Interactions
    Chen, Yuan
    Ma, Fang
    Jones, Nicholas S.
    Yoshida, Kenta
    Chiang, Po-Chang
    Durk, Matthew R.
    Wright, Matthew R.
    Jin, Jin Yan
    Chinn, Leslie W.
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (06): : 332 - 341
  • [9] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug–Drug Interactions
    Ruben de Kanter
    Patricia N. Sidharta
    Stéphane Delahaye
    Carmela Gnerre
    Jerome Segrestaa
    Stephan Buchmann
    Christopher Kohl
    Alexander Treiber
    [J]. Clinical Pharmacokinetics, 2016, 55 : 369 - 380
  • [10] Physiologically-based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potential
    Patel, Nikunjkumar K.
    Chen, Kuan-Fu
    Chen, Shang-Chiung
    Liu, Kai
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (02): : 317 - 329
12345